MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

Search

Perrigo Co PLC

Затворен

СекторЗдравеопазване

27.9 0.87

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

27.39

Максимум

27.93

Ключови измерители

By Trading Economics

Приходи

-24M

-45M

Продажби

51M

1.1B

P/E

Средно за сектора

2,570

63.778

EPS

0.93

Дивидентна доходност

4.14

Марж на печалбата

-3.909

Служители

8,379

EBITDA

35M

114M

Препоръки

By TipRanks

Препоръки

Неутрален

12-месечна прогноза

+20.32% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

4.14%

2.39%

Следващи печалби

6.05.2025 г.

Следваща дата на дивидент

17.06.2025 г.

Следваща дата на екс-дивидент

29.05.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

459M

3.8B

Предишно отваряне

27.03

Предишно затваряне

27.9

Настроения в новините

By Acuity

35%

65%

122 / 386 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Bearish Evidence

Perrigo Co PLC Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

28.02.2025 г., 17:42 ч. UTC

Значими двигатели на пазара

Perrigo Shares Jump on FDA's Move to Reclassify Wisconsin Infant-Formula Plant

27.02.2025 г., 23:52 ч. UTC

Печалби

Perrigo Gets Facility Reclassification From FDA as 4Q Profit, Revenue Fall

Сравнение с други в отрасъла

Ценова промяна

Perrigo Co PLC Прогноза

Ценова цел

By TipRanks

20.32% нагоре

12-месечна прогноза

Среден 33.33 USD  20.32%

Висок 42 USD

Нисък 27 USD

Според 4 анализатори от Wall Street, предложили 12-месечна ценова цел за Perrigo Co PLC през последните три месеца.

Консенсусна оценка

By TipRanks

Неутрален

4 ratings

1

Купи

3

Задържане

0

Продай

Техническа оценка

By Trading Central

27.36 / 27.81Подкрепа & съпротива

Краткосрочен план

Bearish Evidence

Средносрочен план

Bullish Evidence

Дългосрочен план

Strong Bullish Evidence

Настроение

By Acuity

122 / 386 Класиране в Здравеопазване

Настроения в новините

Бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Perrigo Co PLC

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.